OF THE five new hepatitis
C treatments on the market,
Gilead’s combination drug Harvoni
(Ledipasvir/Sofosbuvir) has taken
out line honours in a convincing
way with 68.8% share of scripts
dispensed in new initiations to
March 2016, according to a report
from NostraData.
In other data from the research
company, retail pharmacy total
dispensary value is expected to
drop in value for 2016 and 2017
although the value of prescription
only drugs dispensed increased by
3% year on year last month while
the volume was up only 1%.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Mar 16
IN ANTICIPATION of tonight’s Federal Budget, Kian Ghahramani (pictured), RSM’s National Director for Pharmacy, hopes for significant cost-of-living measures aimed at benefiting consumers and businesses alike.
NSW Minister for Health Ryan Park has announced that from 01 Jun, pharmacists across the state will be authorised permanently to treat uncomplicated urinary tract infections (UTIs), following the successful completion of a 12-month trial (PD breaking news).
THE 2024 Women in Super Mother’s Day Classic (MDC) drew 80,000 participants nationwide, making it Australia’s largest fun run and walk dedicated to breast and ovarian cancer research.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.